These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28980285)

  • 1. Peri-interventional combined anticoagulation and antithrombotic therapy in atrial fibrillation ablation: A retrospective safety analysis.
    Klee K; Widulle D; Duckheim M; Gramlich M; Frische C; Gawaz M; Seizer P; Eick C; Schreieck J
    Cardiol J; 2018; 25(2):213-220. PubMed ID: 28980285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
    Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Bin Abdulhak AA; Khan AR; Tleyjeh IM; Spertus JA; Sanders SU; Steigerwalt KE; Garbati MA; Bahmaid RA; Wimmer AP
    Europace; 2013 Oct; 15(10):1412-20. PubMed ID: 23954918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: A randomized controlled trial.
    Ghannam M; Chugh A; Dillon P; Alyesh D; Kossidas K; Sharma S; Coatney J; Atreya A; Yokokawa M; Saeed M; Cunnane R; Ghanbari H; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2018 Nov; 15(11):1642-1647. PubMed ID: 30661768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.
    Uhm JS; Won H; Joung B; Nam GB; Choi KJ; Lee MH; Kim YH; Pak HN
    Yonsei Med J; 2014 Sep; 55(5):1238-45. PubMed ID: 25048480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Vamos M; Cappato R; Marchlinski FE; Natale A; Hohnloser SH
    Europace; 2016 Dec; 18(12):1787-1794. PubMed ID: 26797248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
    Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
    Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.
    Blandino A; Bianchi F; Biondi-Zoccai G; Grossi S; Conte MR; Rametta F; Gaita F
    J Interv Card Electrophysiol; 2016 Sep; 46(3):225-36. PubMed ID: 27217030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan　- Periprocedural and Long-Term Outcomes.
    Nogami A; Soejima K; Morishima I; Hiroshima K; Kato R; Sakagami S; Miura F; Okawa K; Kimura T; Inoue T; Takita A; Uno K; Kumagai K; Kurita T; Gosho M; Aonuma K;
    Circ J; 2022 Dec; 87(1):50-62. PubMed ID: 35989303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
    Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
    Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
    Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
    Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation.
    Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):155-63. PubMed ID: 25487164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of late thromboembolic events after catheter ablation of atrial fibrillation.
    Yagishita A; Takahashi Y; Takahashi A; Fujii A; Kusa S; Fujino T; Nozato T; Kuwahara T; Hirao K; Isobe M
    Circ J; 2011; 75(10):2343-9. PubMed ID: 21778595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
    Kanaoka K; Nishida T; Iwanaga Y; Nakai M; Tonegawa-Kuji R; Nishioka Y; Myojin T; Okada K; Noda T; Kusano K; Miyamoto Y; Saito Y; Imamura T
    Eur Heart J; 2024 Feb; 45(7):522-534. PubMed ID: 38117227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark.
    Karasoy D; Gislason GH; Hansen J; Johannessen A; Køber L; Hvidtfeldt M; Özcan C; Torp-Pedersen C; Hansen ML
    Eur Heart J; 2015 Feb; 36(5):307-14a. PubMed ID: 25368205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.